Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting

Management options in multiple sclerosis-associated fatigue

(2012) Maria Pia Amato et al.   EXPERT OPINION ON PHARMACOTHERAPY

Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis

(2012) B. Wood et al.   Multiple Sclerosis Journal

Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study

(2012) Pietro Iaffaldano et al.   PLoS One

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

(2011) Murat Yildiz et al.   EUROPEAN NEUROLOGY

Fatigue and progression of corpus callosum atrophy in multiple sclerosis

(2011) Özgür Yaldizli et al.   JOURNAL OF NEUROLOGY

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression

(2011) S. M. Gold et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

(2011) F Patti et al.   Multiple Sclerosis Journal

Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties

(2011) Roy G. Elbers et al.   QUALITY OF LIFE RESEARCH

Relationship of Cortical Atrophy to Fatigue in Patients With Multiple Sclerosis

(2010) Clelia Pellicano et al.   ARCHIVES OF NEUROLOGY

Fatigue and Cognition in Patients with Relapsing Multiple Sclerosis Treated with Interferon Beta

(2010) Maria Melanson et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis

(2009) Stefan M. Gold et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Multiple sclerosis associated fatigue during natalizumab treatment

(2009) Norman Putzki et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue

(2009) IK Penner et al.   Multiple Sclerosis Journal

Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

(2008) Tjalf Ziemssen et al.   Health and Quality of Life Outcomes

Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways

(2008) J Sepulcre et al.   Multiple Sclerosis Journal